Spiro[cyclopropane-1,2'-[2h]indol]-3'(1'H)-one, 95%, 250mg

[2-(5-methyl-1,3,4-thiadiazol-2-yl)ethyl]amine dihydrochloride, 95.0%, 5g

5-Ethyl-6-methylpyridin-3-amine, 1g

Ethyl (2R)-2-methoxypropanoate, 97%, 1g

Colonne capillaire GC ROTI®Cap-FFAP, 25 m, 0,32 mm, 0,25 µm, 1 pièce(s)

3-(4-Methylphenyl)-1,2-oxazole-5-carboxylic acid, 95%, 2.5g

D(+)-glucose monohydraté, min 99,5%, Ph.Eur., 10 kg, emballage plastique.

N-Ethyl acrylamide, 99.0%, 25g

3-Chloro-benzimidic acid ethyl ester; hydrochloride, 95.0%, 2g

Methyl 4-fluoro-1H-pyrrole-2-carboxylate, 95.0%, 25g

6-methoxy-2-(5-methyl-2-furanyl)-N-(1-methyl-4-piperidinyl)-7-[3-(1-pyrrolidinyl)propoxy]-4-quinolinamine, 5mg

5-Chloro-2,4-difluorobenzonitrile, 95.0%, 1g

4-Bromo-3,5-dimethyl-1-(propan-2-yl)-1h-pyrazole, 98%, 5g